Preoperative Maximum Inspiratory Pressure and Outcomes After Interscalene Block in Obese Patients

A Pilot Study on Inspiratory Dynamics and the Effect of Body Mass Index on Respiratory Outcomes After Temporary Hemi Diaphragmatic Paresis Related to Brachial Plexus Blocks

The study aims to explore if Maximum Inspiratory Pressure can predict postoperative breathlessness in obese patients receiving interscalene blocks for shoulder surgery.

The main question is: does baseline Maximum Inspiratory Pressure have any association with postoperative breathlessness after interscalene blocks in class 2 or higher obese patients (BMI>35).

Preoperative and postoperative lung volumes, pressures, breathlessness score and respiratory outcomes will be measured on participants already receiving shoulder surgery with interscalene blocks.

Study Overview

Study Type

Observational

Enrollment (Actual)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • University of North Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Adult patients presenting for shoulder surgery with preoperative interscalene block (Groups 1 and 2). Group 3 includes adult patients presenting for non thoracic, non abdominal surgery under general anesthesia.

Description

Inclusion Criteria Groups 1 and 2

  • Adults >18 years of age receiving shoulder surgery with preoperative interscalene block and general anesthesia;
  • Speak English;

Group 3

· Adults >18 years of age receiving cystoscopy or lower extremity procedures receiving general endotracheal anesthesia

Exclusion Criteria All Groups

  • Less than 18 years of age;
  • currently pregnant;
  • currently incarcerated;
  • those with significant neuromuscular disease, tracheo-bronchial structural abnormalities, severe respiratory or severe cardiovascular comorbidity;
  • those undergoing intra-abdominal or intrathoracic surgeries due to the potential to independently effect breathing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Block, Non-obese
Non-obese, Body Mass Index (BMI)<30, receiving interscalene block and general anesthesia for shoulder surgery
Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day
Other Names:
  • Spirometry measurements, Modified Borg breathlessness questionnaire
Block, Obese
Class 2 or higher Obese, BMI>35, receiving interscalene block and general anesthesia for shoulder surgery
Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day
Other Names:
  • Spirometry measurements, Modified Borg breathlessness questionnaire
Control
control group, included non-shoulder surgery patients receiving general anesthesia only
Lung volumes, pressures and breathlessness scores to be measured in pre and post operative phase of care on the same day
Other Names:
  • Spirometry measurements, Modified Borg breathlessness questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Moderate to Severe Breathlessness
Time Frame: Baseline (Arrival to pre-operative phase), Recovery (Immediately post-surgical, up to 3 hours)
Score of 3 or above on Modified Borg Breathlessness Scale
Baseline (Arrival to pre-operative phase), Recovery (Immediately post-surgical, up to 3 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen Saturation in post-anesthesia care unit
Time Frame: Recovery (Immediately post-surgical, up to 3 hours)
Measured by pulse oximetry
Recovery (Immediately post-surgical, up to 3 hours)
Post-anesthesia care unit length-of-stay
Time Frame: Recovery (Immediately post-surgical, up to 3 hours)
Total time spent in post-operative phase of care
Recovery (Immediately post-surgical, up to 3 hours)
Duration of Oxygen supplementation in post-anesthesia care unit
Time Frame: Recovery (Immediately post-surgical, up to 3 hours)
Total duration of oxygen supplementation in post-operative phase of care
Recovery (Immediately post-surgical, up to 3 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Monika Nanda, University of North Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2023

Primary Completion (Actual)

November 28, 2023

Study Completion (Actual)

January 10, 2024

Study Registration Dates

First Submitted

July 31, 2024

First Submitted That Met QC Criteria

August 7, 2024

First Posted (Actual)

August 12, 2024

Study Record Updates

Last Update Posted (Actual)

August 12, 2024

Last Update Submitted That Met QC Criteria

August 7, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 23-0924

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyspnea After Interscalene Nerve Block

Clinical Trials on Maximum Inspiratory Pressure monitoring

Subscribe